CLG

Cellergy Therapeutics is a biotechnology company focused on the emerging field of mitochondrial medicine to address cellular energy deficits. The company's lead program, CLG-001, utilizes mitochondria purified from healthy donors to restore cellular energy production in patients affected by mitochondrial dysfunction. Cellergy targets a broad range of conditions, including metabolic disorders, neurodegenerative diseases, and age-related conditions. By leveraging a proprietary isolation and purification process, the company aims to deliver clinical-grade mitochondrial therapies to restore health and function at the cellular level.